Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Asenapine> ?p ?o. }
Showing items 1 to 97 of
97
with 100 items per page.
- Asenapine abstract "Asenapine (USAN, rINNM and BANM; trade names Saphris (AU, US), Sycrest (EU, UK)) is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merger with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel. Preliminary data indicate that it has minimal anticholinergic and cardiovascular side effects, as well as minimal weight gain. Over 3000 patients have participated in clinical trials of asenapine, and the FDA accepted the manufacturer's NDA on November 26, 2007 for standard review.It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.".
- Asenapine atcPrefix "N05".
- Asenapine atcSuffix "AH05".
- Asenapine bioavailability "35.0".
- Asenapine casNumber "65576-45-6".
- Asenapine chEBI "71253".
- Asenapine fdaUniiCode "JKZ19V908O".
- Asenapine iupacName "(3aRS,12bRS)-rel-5-Chloro-2,3,3a,12b-tetrahydro-".
- Asenapine iupacName "2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole".
- Asenapine pubchem "163091".
- Asenapine thumbnail Asenapine_Structural_Formulae_V.2.svg?width=300.
- Asenapine wikiPageExternalLink medicalnews.php?newsid=57683.
- Asenapine wikiPageExternalLink www.organon.com.
- Asenapine wikiPageExternalLink www.saphris.com.
- Asenapine wikiPageID "7531191".
- Asenapine wikiPageRevisionID "599344652".
- Asenapine atcPrefix "N05".
- Asenapine atcSuffix "AH05".
- Asenapine bioavailability "35".
- Asenapine c "17".
- Asenapine casNumber "65576".
- Asenapine chebi "71253".
- Asenapine chembl "1201756".
- Asenapine chemspiderid "2300725".
- Asenapine cl "1".
- Asenapine eliminationHalfLife "86400.0".
- Asenapine excretion Feces.
- Asenapine excretion Kidney.
- Asenapine h "16".
- Asenapine hasPhotoCollection Asenapine.
- Asenapine image "Asenapine3Dan.gif".
- Asenapine iupacName "-rel-5-Chloro-2,3,3a,12b-tetrahydro-".
- Asenapine iupacName "2".
- Asenapine iupharLigand "22".
- Asenapine legalAu "S4".
- Asenapine legalUk "POM".
- Asenapine legalUs "Rx-only".
- Asenapine licenceEu "Sycrest".
- Asenapine licenceUs "Asenapine".
- Asenapine medlineplus "a610015".
- Asenapine metabolism "hepatic".
- Asenapine molecularWeight "285.77".
- Asenapine n "1".
- Asenapine o "1".
- Asenapine pregnancyAu "C".
- Asenapine pregnancyUs "C".
- Asenapine proteinBound "95.0".
- Asenapine pubchem "163091".
- Asenapine routesOfAdministration "sublingual".
- Asenapine smiles "Clc4cc2ccc4".
- Asenapine stdinchi "1".
- Asenapine stdinchikey "VSWBSWWIRNCQIJ-GJZGRUSLSA-N".
- Asenapine tradename "Saphris, Sycrest".
- Asenapine unii "JKZ19V908O".
- Asenapine verifiedfields "changed".
- Asenapine verifiedrevid "457820862".
- Asenapine watchedfields "changed".
- Asenapine width "225".
- Asenapine width "275".
- Asenapine subject Category:Atypical_antipsychotics.
- Asenapine subject Category:Organochlorides.
- Asenapine subject Category:Oxepines.
- Asenapine subject Category:Pyrrolidines.
- Asenapine subject Category:Receptor_modulators.
- Asenapine type Agent114778436.
- Asenapine type AtypicalAntipsychotics.
- Asenapine type CausalAgent100007347.
- Asenapine type Drug103247620.
- Asenapine type DrugOfAbuse103248958.
- Asenapine type MajorTranquilizer103713736.
- Asenapine type Matter100020827.
- Asenapine type Medicine103740161.
- Asenapine type PhysicalEntity100001930.
- Asenapine type PsychotropicAgent104017429.
- Asenapine type Sedative-hypnotic104166841.
- Asenapine type Sedative104166553.
- Asenapine type Substance100020090.
- Asenapine type Tranquilizer104470232.
- Asenapine type Drug.
- Asenapine type DrugProduct.
- Asenapine type FunctionalSubstance.
- Asenapine comment "Asenapine (USAN, rINNM and BANM; trade names Saphris (AU, US), Sycrest (EU, UK)) is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merger with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel.".
- Asenapine label "Asenapin".
- Asenapine label "Asenapina".
- Asenapine label "Asenapina".
- Asenapine label "Asenapine".
- Asenapine label "Азенапин".
- Asenapine sameAs Asenapin.
- Asenapine sameAs Asenapina.
- Asenapine sameAs Asenapina.
- Asenapine sameAs m.0264jhb.
- Asenapine sameAs Q416545.
- Asenapine sameAs Q416545.
- Asenapine sameAs Asenapine.
- Asenapine wasDerivedFrom Asenapine?oldid=599344652.
- Asenapine depiction Asenapine_Structural_Formulae_V.2.svg.
- Asenapine isPrimaryTopicOf Asenapine.